On the recordSeptember 20, 2016
I mean, is that your testimony?
Source
congress.govEditor's note · Context
DesJarlais questions the justification for the price drop of EpiPens.
Share & report
More from Scott DesJarlais
May 20, 2013
I continue to be concerned about the runaway cost of the Pell Grant program.
Jul 13, 2015
I think it has been reiterated a number of times today that we feel that this is a much better deal for Iran than it is the United States.
Other voices in this conversation
